Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Estrogen receptor mutations detected in plasma associated with worse overall...
Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA
Estrogen receptor mutations detected in plasma associated with worse overall survival in metastatic breast cancer ( Dr Sarat Chandarlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )
11 Dec 2015
Analysis of blood samples finds ESR1 gene mutations are prevalent and...
Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA
Analysis of blood samples finds ESR1 gene mutations are prevalent and associated with worse overall survival ( Dr Sarat Chanderlapaty - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Dec 2015
Denosumab improves disease-free survival for postmenopausal patients with HR...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
9 Dec 2015
Denosumab improves disease-free survival for postmenopausal HR-positive breast...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
Pathologic complete response to presurgery chemo improves survival for triple...
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
9 Dec 2015
The POSEIDON trial of the EurocanPlatform project
Dr Richard Baird - Cambridge Cancer Centre, Cambridge, UK
The POSEIDON trial of the EurocanPlatform project ( Dr Richard Baird - Cambridge Cancer Centre, Cambridge, UK )
4 Dec 2015
Mouse tumour models in the EurocanPlatform project
Prof Anton Berns - Netherlands Cancer Institute (NKI), Amsterdam, The...
Mouse tumour models in the EurocanPlatform project ( Prof Anton Berns - Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands )
4 Dec 2015
Cancer Core Europe: where did it come from and what is its future?
Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark
Cancer Core Europe: where did it come from and what is its future? ( Prof Julio Celis - Danish Cancer Society Research Center, Copenhagen, Denmark )
4 Dec 2015
Cancer Core Europe: what has been achieved one year on?
Prof Alexander Eggermont and Prof Julio Celis
Cancer Core Europe: what has been achieved one year on? ( Prof Alexander Eggermont and Prof Julio Celis )
2 Dec 2015
Highlights of the EurocanPlatform Project
Highlights of the EurocanPlatform Project ( )
2 Dec 2015
Cancer Core Europe: one year on (full version)
Prof Alexander Eggermont - Gustave Roussy, Villejuf, France
Cancer Core Europe: one year on (full version) ( Prof Alexander Eggermont - Gustave Roussy, Villejuf, France )
2 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation